marketcaparena
Search

    CNXU

    Conexeu Sciences Inc.

    Company overview

    Market capitalization
    $106.34M
    Employees
    —
    Latest publication
    2026-09-29
    About Conexeu Sciences Inc.

    Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-01-31 · USDQ1 20252025-01-31 · USD
    Total Revenue0USD0USD
    Research Development62,562USD23,667USD
    Selling General Administrative1,546,201USD270,608USD
    Total Operating Expenses1,720,927USD332,721USD
    Operating Income-1,720,927USD-332,721USD
    Interest Income11,290USD0USD
    Interest Expense0USD3,610USD
    Net Interest Income9,259USD-4,342USD
    Income Before Tax-1,718,823USD-290,064USD
    Tax Provision0USD0USD
    Net Income-1,718,823USD-290,064USD
    Net Income From Continuing Ops-1,718,823USD-290,064USD
    Reconciled Depreciation6,440USD563USD
    Total Other Income Expense Net-7,155USD46,999USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-10-31 · USDFY 20242024-10-31 · USD
    Total Revenue0USD0USD
    Research Development272,699USD237,729USD
    Selling General Administrative3,453,347USD362,961USD
    Total Operating Expenses3,958,329USD643,042USD
    Operating Income-3,958,329USD-643,042USD
    Interest Income1,731USD0USD
    Interest Expense4,949USD16,505USD
    Net Interest Income-7,335USD-17,346USD
    Income Before Tax-3,923,557USD-471,867USD
    Tax Provision0USD0USD
    Net Income-3,923,557USD-471,867USD
    Net Income From Continuing Ops-3,923,557USD-471,867USD
    Reconciled Depreciation17,250USD0USD
    Total Other Income Expense Net42,107USD188,521USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-07-31 · USDQ1 20262026-01-31 · USD
    Total Assets7,156,074USD7,702,677USD
    Cash And Equivalents1,971,408USD—
    Total Current Assets6,756,316USD7,458,591USD
    Total Liabilities1,305,684USD—
    Total Current Liabilities1,272,451USD876,275USD
    Total Stockholder Equity5,850,390USD6,826,402USD
    Total Equity Including Noncontrolling Interest5,850,390USD—
    Property Plant Equipment Net145,959USD11,144USD
    Accounts Payable784,158USD399,297USD
    Short Term Debt39,249USD—
    Common Stock27,397USD—
    Retained Earnings-16,270,277USD-6,240,343USD
    Intangible Assets—172,541USD
    Total Liab—876,275USD
    Other Current Liab—473,256USD
    Capital Stock—19,846USD
    Cash—6,255,388USD
    Property Plant Equipment Gross—19,026USD
    Common Stock Shares Outstanding—20,916,173shares
    Non Current Assets Total—244,086USD
    Non Current Liabilities Total—0USD
    Net Working Capital—6,582,316USD
    Unclassified Current Assets—1,203,203USD
    Unclassified Equity—13,046,899USD
    SourceDisclosureDeterministicFinalLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-10-31 · USDFY 20242024-10-31 · USD
    Total Assets7,688,711USD533,940USD
    Intangible Assets176,884USD186,703USD
    Total Liab336,018USD438,976USD
    Total Stockholder Equity7,352,693USD94,964USD
    Capital Stock18,906USD8,528USD
    Retained Earnings-4,521,520USD-597,963USD
    Cash4,808,965USD314,616USD
    Total Current Assets7,458,413USD347,237USD
    Total Current Liabilities336,018USD340,859USD
    Accounts Payable256,296USD319,024USD
    Property Plant Equipment Net11,237USD0USD
    Property Plant Equipment Gross18,668USD0USD
    Common Stock Shares Outstanding20,916,173shares20,916,173shares
    Non Current Assets Total230,298USD186,703USD
    Non Current Liabilities Total0USD98,117USD
    Net Working Capital7,122,395USD6,378USD
    Unclassified Current Assets2,649,448USD—
    Unclassified Equity11,855,307USD—
    Long Term Debt—98,117USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-07-31 · USD
    Depreciation23,296USD
    Stock Based Compensation1,493,977USD
    Change To Liabilities524,865USD
    Change In Working Capital448,865USD
    Operating Cash Flow-10,099,279USD
    Capital Expenditures-76,229USD
    Unclassified Investing Cash Flow-2USD
    Investing Cash Flow-76,231USD
    Financing Cash Flow7,548,009USD
    Effect Of Forex Changes On Cash2,997USD
    Change In Cash-2,624,504USD
    End Cash Flow2,209,616USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-01-31 · USDQ1 20252025-01-31 · USD
    Net Income-1,718,823USD-290,064USD
    Depreciation6,440USD563USD
    Stock Based Compensation0USD66,000USD
    Other Non Cash Items186,733USD-16,490USD
    Change In Working Capital-13,447USD4,138USD
    Total Cash From Operating Activities-1,536,356USD-235,853USD
    Capital Expenditures-4,744USD-13,508USD
    Free Cash Flow-1,541,100USD-249,361USD
    Total Cash From Financing Activities3,416,131USD550,000USD
    Issuance Of Capital Stock3,005,299USD550,000USD
    Change In Cash1,875,031USD300,639USD
    Begin Period Cash Flow4,834,120USD314,616USD
    End Period Cash Flow6,709,151USD612,273USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-10-31 · USDFY 20242024-10-31 · USD
    Net Income-3,923,557USD-471,867USD
    Depreciation17,250USD0USD
    Stock Based Compensation1,344,376USD6,807USD
    Other Non Cash Items794,368USD-218,182USD
    Change In Working Capital97,588USD422,571USD
    Total Cash From Operating Activities-1,669,975USD-225,439USD
    Capital Expenditures-18,668USD0USD
    Free Cash Flow-1,688,643USD-225,439USD
    Net Borrowings-94,206USD0USD
    Total Cash From Financing Activities6,283,384USD534,637USD
    Issuance Of Capital Stock6,423,957USD531,000USD
    Change In Cash4,523,415USD309,198USD
    Begin Period Cash Flow314,616USD0USD
    End Period Cash Flow4,834,120USD314,616USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.